Luclips Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the enzyme lanosterol 14α-demethylase, which is essential for ergosterol synthesis, a critical component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. Luclips Cream is effective against a broad spectrum of dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes, as well as yeasts like Candida species and Malassezia furfur. The cream is intended for topical application to the affected area once daily, typically for a duration of 1 to 2 weeks depending on the infection type and severity. It is generally well tolerated, with minimal adverse effects such as mild local irritation or burning sensation. Luclips Cream should be used with caution in patients with known hypersensitivity to luliconazole or other imidazole antifungals. Proper hygiene and adherence to the prescribed treatment regimen are essential to ensure optimal therapeutic outcomes and prevent recurrence of infection.